AstraZeneca News – AstraZeneca PLC ADR outperforms competitors despite losses on the day

The AstraZeneca PLC ADR
(AZN),
-0.53%
sank 0.53% to $48.91 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index
COMP,
-3.52%
falling 3.52% to 13,119.43 and Dow Jones Industrial Average
DJIA,
-1.75%
falling 1.75% to 31,402.01. AstraZeneca PLC ADR closed $16.03 short of its 52-week high ($64.94), which the company reached on July 20th.

Despite its losses, the ADR outperformed some of its competitors Thursday, as AbbVie Inc.
ABBV,
-1.25%
fell 1.25% to $107.33, Amgen Inc.
AMGN,
-1.07%
fell 1.07% to $227.52, and Gilead Sciences Inc.
GILD,
-1.44%
fell 1.44% to $62.79.true Trading volume (12.8 M) remained 239,248 below its 50-day average volume of 13.0 M.